Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€25.75

€25.75

0.190%
0.05
0.190%
€40.22

€40.22

 
28.03.24 / Tradegate WKN: 852009 / Symbol: PFE / Name: Pfizer / Stock / Pharmaceuticals / Large Cap /
Latest predictions
25.03.24
1.78%
€30.00
21.03.24
0.59%
buy
17.03.24
0.59%
buy
€41.51
01.03.24
4.89%
buy
€33.22
23.02.24
0.78%
buy
€18.00
15.02.24
0.98%
Your prediction

Pfizer Inc. Stock

The Pfizer Inc. stock is trending slightly upwards today, with an increase of €0.050 (0.190%) compared to yesterday's price.
With 28 Buy predictions and 4 Sell predictions Pfizer Inc. is one of the favorites of our community.
With a target price of 40 € there is a hugely positive potential of 55.34% for Pfizer Inc. compared to the current price of 25.75 €.
Our community identified positive and negative aspects for Pfizer Inc. stock for the coming years. 14 users see the criterium "Worthwhile Investment for the next years" as a plus for the Pfizer Inc. stock. On the other hand our users think that "Conscious of the environment" could be a problem in the future.

Pros and Cons of Pfizer Inc. in the next few years

Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
B****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Pfizer Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Pfizer Inc. 0.190% 0.783% 3.000% -30.141% -1.341% -16.028% -27.856%
Biogen Inc. 0.100% -2.257% -2.639% -20.048% -15.522% -14.963% -4.254%
Elanco Animal Health Inc. 1.230% -0.533% 1.633% 81.377% 10.503% -36.722% -
AbbVie Inc. 1.320% 3.180% 2.678% 15.643% 20.414% 87.778% 136.275%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-15

Upon first glance, the financials of Pfizer Inc. (NYSE: PFE) appear to be strong, showcasing a robust position in the pharmaceuticals industry. As a prominent player, Pfizer has consistently demonstrated growth in its total assets and revenue, laying the foundation for a favorable outlook on the company's performance. As we dive deeper into the financial statements, it becomes essential to analyze the pros and cons to acquire a comprehensive understanding of Pfizer's financial health and future potential.

*Pros: *

Growing Total Assets and Shareholders' Equity: The company's total assets have grown consistently over the past three years, from approximately €154.2 billion in 2020 to €181.5 billion in 2021, and reaching a notable USD 197.2 billion in 2022. Such growth indicates strong financial management and an increased capacity to generate income. Similarly, the total stockholder equity has also risen, reflecting the company's ability to create value for its shareholders.

Comments

Prediction Buy
Perf. (%) 4.89%
Target price 41.513
Change
Ends at 01.03.25

Pfizer Inc. (NYSE: PFE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.78%
Target price 33.224
Change
Ends at 23.02.25

Pfizer Inc. (NYSE: PFE) is now covered by analysts at Guggenheim. They set a "buy" rating and a $36.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 1.98%
Target price 41.472
Change
Ends at 31.01.25

Pfizer Inc. (NYSE: PFE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Show more

News

2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold Forever: https://g.foolcdn.com/editorial/images/770308/individual-investors-at-home-getty.jpg
2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold Forever

Few things are more satisfying than watching a steadily growing stream of passive income flow into your brokerage account. If you've been holding back from investing because you think you can't

Cathie Wood Is Selling This High-Yield Dividend Stock. Should You?: https://g.foolcdn.com/editorial/images/770269/sell-stock.jpg
Cathie Wood Is Selling This High-Yield Dividend Stock. Should You?

Cathie Wood and high dividend yields go together like... well, it's hard to finish that sentence because they don't go together at all. Wood and her Ark Invest funds are known for investing in

A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now: https://g.foolcdn.com/editorial/images/769710/dog-with-owners-looking-at-laptop.jpg
A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now

Does a rising tide really lift all boats? We could soon find out if the adage applies to the stock market.

A bull market is now well underway. The S&P 500 has soared more than 30% over the last 12